Aktieanalys på Doxa Q2-18
Analyst Group publicerade den 4 september 2018 en aktieanalys på Doxa.
Comment
2024-06-26
Comment on ODI Pharma’s Strategic Market Entry to Switzerland
Equity research report
2024-06-05
ODI Pharma Q1-24
2024-05-08
STENOCARE Q1-24
2024-05-06
ODI Pharma
Video
Interview with ODI Pharma’s Chairman of the Board Volker Wiederrich